BRCA1 and ovarian carcinoma: In addition, a dominantly inherited 5′ UTR BRCA1 variant was recently shown to be associated with BRCA1 promoter hypermethylation, which is known to impact TF binding, and associated allelic loss of BRCA1 expression in two families affected by breast and ovarian cancers (Evans et al., 2018).